Medifast
MED
225 hedge funds and large institutions have $1,000M invested in Medifast in 2018 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 66 increasing their positions, 75 reducing their positions, and 23 closing their positions.
113% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 23
36% more capital invested
Capital invested by funds: $736M → $1,000M (+$264M)
22% more call options, than puts
Call options by funds: $6.71M | Put options by funds: $5.52M
12% more funds holding
Funds holding: 201 → 225 (+24)
0.49% more ownership
Funds ownership: 88.36% → 88.85% (+0.49%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 75
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MWNA
Marshall Wace North America
New York
|
+$8.85M |
| 2 |
Millennium Management
New York
|
+$8.81M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.5M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$6.28M |
| 5 |
CM
Castleark Management
Chicago,
Illinois
|
+$4.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
Engaged Capital
Newport Beach,
California
|
-$18.5M |
| 2 |
BlackRock
New York
|
-$6.63M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$5.58M |
| 4 |
LCM
Laurion Capital Management
New York
|
-$5.28M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$4.87M |
MED Hedge Fund Activity: Q1 2018 in Review
225 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q1 2018, worth a combined $1,000M — up 36% from $736M a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new MED positions and 23 closed out — a net gain of 26 holders — while 66 added to existing stakes and 75 trimmed.
The largest buyer was Marshall Wace North America, adding an estimated $8.85M. The largest seller was Engaged Capital, exiting entirely with an estimated $18.5M sold.
- 225 institutional investors held Medifast (MED) as of Q1 2018, up from 201 in Q4 2017.
- Funds reported $1,000M of Medifast stock for Q1 2018, up 36% quarter-over-quarter.
- 49 funds opened new Medifast positions in Q1 2018 and 23 closed out, a net change of +26 holders.
- The largest Medifast buyer in Q1 2018 was Marshall Wace North America, an estimated $8.85M added.
- The largest Medifast seller in Q1 2018 was Engaged Capital, an estimated $18.5M sold.
Based on aggregated 13F filings for Q1 2018.